Sign in
TerminatedPhase 1

First-In-Human Study of AK1320 Encapsulated Microspheres (AK1320 MS)

Key facts

Who runs it
Asahi Kasei Therapeutics Corporation
Where
Canada7 sites in 1 countryChoose a country to see its sites
Trial code
Status
Terminated
Phase
Phase 1
People taking part
30 people enrolled
Started
18 Nov 2020
Ended
30 Jan 2024
Type of study
Interventional, 2 groups
Treatments tested
  • AK1320 MS
  • Control
Record updated
6 March 2024
Why it stopped
Sponsor decision

Who can take part

Age
22 years to 80 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 13 criteriaShow less

Who can take part

  • Involved level L1 to S1
  • Use of local autologous bone only
  • Degenerative spondylolisthesis up to Meyerding's Classification Grade 1 or 2
  • Moderate or higher disability as assessed by Oswestry Disability Index
  • Neurogenic claudication and/or radiculopathy with or without back pain
  • Male or female over 22 years of age and less than 81 years of age

Who cannot take part

  • Prior lumbar decompression or spine fusion attempt (any level)
  • Undergoing concurrent interbody fusion
  • Requires spinal fusion at more than one lumbar level
  • Degenerative scoliosis
  • BMI > 40
  • Radiographically confirmed significant spinal instability
  • Active or recent (within the past two (2) years) worker's compensation litigation

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The safety and efficacy of AK1320 MS will be evaluated in patients with degenerative spondylolisthesis and concomitant symptomatic spinal stenosis who are undergoing decompression and single level instrumented posterolateral lumber autograft fusion surgery.

The 2 groups in the trial

  • AK1320 MSTreatment being tested

    AK1320 MS + Local Autologous Bone + Posterior Fixation

  • ControlOther group

    Local Autologous Bone + Posterior Fixation

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
First-In-Human Study of AK1320 Encapsulated Microspheres (AK1320 MS) In Subjects With Degenerative Spondylolisthesis and Concomitant Symptomatic Spinal Stenosis Who Are Undergoing Decompression And Single Level Instrumented Posterolateral Lumbar Autograft Fusion Surgery
Record updated
6 March 2024